Showing results (1-10 of 888) with videos related to
Sort By:
Pageof 89
British Journal of Hospital Medicine (London, England : 2005)|August 18, 2009
Treatment of dementia: where is it going?Chris Fox, Malaz Boustani, Esme Moniz-CookNeuropsychiatric Disease and Treatment|May 5, 2009
Memantine combined with an acetyl cholinesterase inhibitor - hope for the future?Chris Fox, Ian D Maidment, Malaz Boustani, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Dementia Care Research and Psychosocial FactorsMalaz BoustaniBMJ Open|March 19, 2018
Dementia case-finding in hospitals: a qualitative study exploring the views of healthcare professionals in English primary care and secondary careAnne-Marie Burn, Jane Fleming, Carol Brayne, et al.Age and Ageing|September 20, 2011
The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD studyChris Fox, Gill Livingston, Ian D Maidment, et al.BMC Geriatrics|October 23, 2019
Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort studyCarlota M Grossi, Kathryn Richardson, Chris Fox, et al.American Journal of Epidemiology|May 22, 2019
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control StudyKathryn Richardson, Katharina Mattishent, Yoon K Loke, et al.Journal of Alzheimer'S Disease : JAD|March 3, 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseKathryn Richardson, Stephen B Wharton, Carlota M Grossi, et al.Clinical Interventions in Aging|January 30, 2008
The challenge of supporting care for dementia in primary careMalaz Boustani, Cathy Schubert, Youcef SennourBMJ (Clinical Research Ed.)|April 27, 2018
Anticholinergic drugs and risk of dementia: case-control studyKathryn Richardson, Chris Fox, Ian Maidment, et al.Pageof 89